Rosenberg Ellen's Form 4 filing
Amicus Therapeutics, Inc.FOLD · filed Feb 8, 2024
- Accession no.
- 0000950170-24-012843
- Filed
- Feb 8, 2024
- Trade date
- Feb 6-7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $390.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosenberg EllenCIK 0001666380 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | MOption exerciseAcquired | +400 | $5.16 | +$2,064 | 368,054 | Direct | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −400 | $13.00 | −$5,200 | 367,654 | Direct | |
| Feb 7, 2024 | Common Stock | MOption exerciseAcquired | +29,600 | $5.16 | +$152,736 | 397,254 | Direct | |
| Feb 7, 2024 | Common Stock | SSaleDisposed | −29,600 | $13.00F1 | −$384,800 | 367,654 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 29,600 | Direct | |
| Feb 7, 2024 | Common Stock | MOption exerciseDisposed | −29,600 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.00 to $13.01 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2023.